Publications by authors named "Gordon Parry"

Claim this Profile
R
Regression of renal cell carcinoma by T cell receptor-engineered T cells targeting a human endogenous retrovirus.
Stefan Barisic, Elizabeth M Brahmbhatt, Elena Cherkasova, Timothy T Spear, Ujjawal Savani, Gordon Parry

J Immunother Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer.
Allan Lipton, Laurie Goodman, Kim Leitzel, Jennifer Cook, Jeff Sperinde, Gordon Parry

Breast Cancer Res Treat· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative assays for the measurement of HER1-HER2 heterodimerization and phosphorylation in cell lines and breast tumors: applications for diagnostics and targeted drug mechanism of action.
Lisa DeFazio-Eli, Kristi Strommen, Trang Dao-Pick, Gordon Parry, Laurie Goodman

Breast Cancer Res· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of hepatocyte growth factor (HGF) ligand-c-MET receptor activation in formalin-fixed paraffin embedded specimens by a novel proximity assay.
Rajiv Dua, Jianhuan Zhang, Gordon Parry, Elicia Penuel

PLoS One· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling the HER3/PI3K pathway in breast tumors using proximity-directed assays identifies correlations between protein complexes and phosphoproteins.
Ali Mukherjee, Youssouf Badal, Xuan-Thao Nguyen, Johanna Miller, Ahmed Chenna, Gordon Parry

PLoS One· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGFR over-expression and activation in high HER2, ER negative breast cancer cell line induces trastuzumab resistance.
Rajiv Dua, Jianhuan Zhang, Phets Nhonthachit, Elicia Penuel, Chris Petropoulos, Gordon Parry

Breast Cancer Res Treat· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitation of p95HER2 in paraffin sections by using a p95-specific antibody and correlation with outcome in a cohort of trastuzumab-treated breast cancer patients.
Jeff Sperinde, Xueguang Jin, Jayee Banerjee, Elicia Penuel, Anasuya Saha, Gordon Parry

Clin Cancer Res· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analytical Validation of a Highly Quantitative, Sensitive, Accurate, and Reproducible Assay (HERmark) for the Measurement of HER2 Total Protein and HER2 Homodimers in FFPE Breast Cancer Tumor Specimens.
Jeffrey S Larson, Laurie J Goodman, Yuping Tan, Lisa Defazio-Eli, Agnes C Paquet, Gordon Parry

Patholog Res Int· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo biodistribution, PET imaging, and tumor accumulation of 86Y- and 111In-antimindin/RG-1, engineered antibody fragments in LNCaP tumor-bearing nude mice.
Douglas W Schneider, Tara Heitner, Bruno Alicke, David R Light, Kirk McLean, Gordon Parry, Renate Parry

J Nucl Med· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepsin and prostate cancer.
Qingyu Wu, Gordon Parry

Front Biosci· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture.
Jian-Ai Xuan, Doug Schneider, Pam Toy, Rick Lin, Alicia Newton, Renate Parry, Gordon Parry

Cancer Res· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a novel prostate tumor target, mindin/RG-1, for antibody-based radiotherapy of prostate cancer.
Renate Parry, Doug Schneider, Debra Hudson, Debbie Parkes, Jian-Ai Xuan, Gordon Parry

Cancer Res· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting tomoregulin for radioimmunotherapy of prostate cancer.
Xiao-Yan Zhao, Doug Schneider, Sandra L Biroc, Renate Parry, Bruno Alicke, Gordon Parry

Cancer Res· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiplex gene expression analysis for high-throughput drug discovery: screening and analysis of compounds affecting genes overexpressed in cancer cells.
Paul H Johnson, Roger P Walker, Steven W Jones, Kathy Stephens, Janet Meurer, Gordon Parry

Mol Cancer Ther· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis